KRMD (KORU Medical Systems) EPS (Basic): $-0.05 (TTM As of Mar. 2026)


KRMD KORU Medical Systems Inc KRMD
76 GF Score
Price $4.43
GF Value $4.08
Valuation Fairly Valued
View Full Analysis

What is KORU Medical Systems EPS (Basic)?

KORU Medical Systems KRMD -3.49% 76 EPS (Basic) is $-0.05 as of Mar. 2026. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued).

KORU Medical Systems's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.05.

KORU Medical Systems's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.05.

KORU Medical Systems's EPS without NRI for the three months ended in Mar. 2026 was $-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, KORU Medical Systems's highest 3-Year average EPS without NRI Growth Rate was 58.80% per year. The lowest was -22.60% per year. And the median was 0.80% per year.

KORU Medical Systems  (NAS:KRMD) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

KORU Medical Systems EPS (Basic) Related Terms

KORU Medical Systems EPS (Basic) Historical Data

* Premium members only.

The historical data trend for KORU Medical Systems's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KORU Medical Systems EPS (Basic) Chart

KORU Medical Systems Annual Data
Trend Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.10 -0.19 -0.30 -0.13 -0.06

KORU Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 0.00 -0.02 -0.01 -0.02
KRMD
76GF Score
KORU Medical Systems Inc KRMD
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KORU Medical Systems EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

KORU Medical Systems's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-2.638-0)/46.187
=-0.06

KORU Medical Systems's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.807-0)/46.365
=-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.05 mean?
KORU Medical Systems (KRMD) has a EPS (Basic) of $-0.05 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on KORU Medical Systems and its competitors.
Is KORU Medical Systems' EPS (Basic) too high?
KORU Medical Systems' current EPS (Basic) is $-0.05. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' EPS (Basic) compare to EMBC and PDEX?
KORU Medical Systems' EPS (Basic) of $-0.05 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on KORU Medical Systems and its competitors. KORU Medical Systems's current EPS (Basic) is $-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.43 — trading 8.6% above its estimated fair value. The current EPS (Basic) is $-0.05. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current EPS (Basic) is $-0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued. The current stock price of $4.43 is trading 8.6% above its estimated GF Value™ of $4.08. GuruFocus considers KORU Medical Systems to be Fairly Valued.

Key valuation signals for KRMD:

  • EPS (Basic): $-0.05
  • GF Value™: $4.08 vs. price of $4.43 (8.6% above fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KORU Medical Systems Business Description

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score

Get the complete analysis for KRMD

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.43
Price
$4.08
GF Value